C4 Therapeutics Inc (CCCC) — Financial Flexibility Index
C4 Therapeutics Inc (CCCC) has a Financial Flexibility Index of -0.22x as of December 2025. Free cash flow of $-22.13 Million (operating CF $-22.14 Million minus capex $11.00K) represents 0% of total liabilities ($102.49 Million). Also explore C4 Therapeutics Inc (CCCC) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
C4 Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for C4 Therapeutics Inc across 8 annual periods. Check CCCC strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for C4 Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for C4 Therapeutics Inc. For the full company profile including market capitalisation, see C4 Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-98.09 Million | $-98.69 Million | $102.49 Million | ▼ -96.8% |
| 2024 | -0.49x | $-64.98 Million | $-65.16 Million | $133.62 Million | ▲ +39.7% |
| 2023 | -0.81x | $-105.13 Million | $-106.84 Million | $130.34 Million | ▼ -13.7% |
| 2022 | -0.71x | $-100.44 Million | $-105.94 Million | $141.61 Million | ▲ +3.0% |
| 2021 | -0.73x | $-85.69 Million | $-86.97 Million | $117.16 Million | ▼ -31.1% |
| 2020 | -0.56x | $-66.60 Million | $-67.25 Million | $119.35 Million | ▼ -325.5% |
| 2019 | 0.25x | $56.96 Million | $55.61 Million | $230.22 Million | ▲ +491.7% |
| 2018 | -0.06x | $-14.29 Million | $-16.98 Million | $226.24 Million | — |